Status:
COMPLETED
Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
The survey is conducted to collect safety and effectiveness information on the use of Pramipexole for long time of period in daily clinical settings in Japan.
Eligibility Criteria
Inclusion
- Patients with Parkinson's disease
Exclusion
- Patients should have been treated according to the Japanese insert slip
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1645 Patients enrolled
Trial Details
Trial ID
NCT00615914
Start Date
February 1 2004
Last Update
July 11 2014
Active Locations (273)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Agano, Japan
2
Boehringer Ingelheim Investigational Site
Aizu-Wakamatsu, Japan
3
Boehringer Ingelheim Investigational Site
Akashi, Japan
4
Boehringer Ingelheim Investigational Site
Akita, Japan